Bryant has enjoyed nearly 25 years in the clinical research domain, mostly comprised of industry leadership in clinical data management and clinical operations. Bryant has led workstreams in the identification of innovative and transformative processes and tools for clinical data environments and supported departments in clinical data standards and HEOR research. Bryant is currently the Senior Director, SCA Go-To-Market/Strategy, where he ensures seamless coordination and oversight between commercialization, marketing, strategy and corporate development operations for external control arm solutions. Bryant holds a Master of Science in Epidemiology from Columbia University.
AI and Data Sciences Showcase:
Medidata AI serve 1,300 customers and partners worldwide and empower more than 150,000 certified users every day to create hope for millions of patients.
Methods to Accelerate Technical and Regulatory Success
Rigorous study of historic patient-level clinical trial data and real-world data may accelerate drug development.
The PMWC 2023 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.